154 related articles for article (PubMed ID: 219017)
1. Antibody reactivity to human and vervet cytomegalovirus early antigen(s) in sera from patients with active cytomegalovirus infections and from asymptomatic donors.
Waner JL; Biano SA
J Clin Microbiol; 1979 Jan; 9(1):134-40. PubMed ID: 219017
[TBL] [Abstract][Full Text] [Related]
2. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
[TBL] [Abstract][Full Text] [Related]
3. Little role of anti-gB antibodies in neutralizing activity of patient's sera with human cytomegalovirus (HCMV) infection.
Park JW; Kim DJ; Kim J; Park CG; Hwang ES; Cha CY
J Korean Med Sci; 2000 Apr; 15(2):133-8. PubMed ID: 10803687
[TBL] [Abstract][Full Text] [Related]
4. Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
Kim MN; Park CG; Hwang ES; Lim DG; Park JW; Seoh JY; Kook YH; Lee HJ; Choi SB; Cha CY
J Korean Med Sci; 1994 Dec; 9(6):476-81. PubMed ID: 7786444
[TBL] [Abstract][Full Text] [Related]
5. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
Gergely L; Czeglédy J; Váczi L
Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
[TBL] [Abstract][Full Text] [Related]
6. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
Weber B; Braun W; Cinatl J; Doerr HW
Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
[TBL] [Abstract][Full Text] [Related]
7. Antibodies against human CMV-induced "early" antigens detected by immunoblotting are not exclusively associated with active infection.
Hamann A; Braun W; Doerr HW
Res Virol; 1991; 142(1):33-7. PubMed ID: 1647051
[TBL] [Abstract][Full Text] [Related]
8. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
[TBL] [Abstract][Full Text] [Related]
9. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
[TBL] [Abstract][Full Text] [Related]
10. Analysis by immunoblotting of human cytomegalovirus antibody in sera of renal transplant recipient.
Shimokawa K; Murayama T; Ishida S; Furukawa T
J Med Virol; 1987 Apr; 21(4):339-46. PubMed ID: 3035072
[TBL] [Abstract][Full Text] [Related]
11. Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.
Gergely L; Gzeglédy J; Váczi L
Med Microbiol Immunol; 1981; 170(2):99-108. PubMed ID: 6275252
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot.
Braun W; Weber B; Moell U; Hamann A; Doerr HW
J Virol Methods; 1993 Jun; 43(1):65-75. PubMed ID: 8395539
[TBL] [Abstract][Full Text] [Related]
13. The immune response to human cytomegalovirus-induced early nuclear and early membrane antigens and its possible clinical significance.
Landini MP; Lazzarotto T; La Placa M
J Infect; 1984 Nov; 9(3):257-63. PubMed ID: 6098617
[TBL] [Abstract][Full Text] [Related]
14. Humoral immune response to functional regions of human cytomegalovirus glycoprotein B.
Navarro D; Lennette E; Tugizov S; Pereira L
J Med Virol; 1997 Aug; 52(4):451-9. PubMed ID: 9260696
[TBL] [Abstract][Full Text] [Related]
15. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
16. Comparison of occurrence of antibodies to human cytomegalovirus as demonstrated by immunofluorescence and indirect hemagglutination techniques.
Michelson S; Cabau N; Boue A; Horodniceanu F
J Clin Microbiol; 1979 Jan; 9(1):149-51. PubMed ID: 219018
[TBL] [Abstract][Full Text] [Related]
17. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
Weber B; Fall EM; Berger A; Doerr HW
J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
[TBL] [Abstract][Full Text] [Related]
18. Comparison of simian and human cytomegalovirus reactivities in an enzyme-linked immunospecific assay: effect of antigen preparation on cross-reactive antigens.
Tinghitella TJ; Swack N; Baumgarten A; Hsiung GD
Infect Immun; 1982 Aug; 37(2):823-5. PubMed ID: 6288573
[TBL] [Abstract][Full Text] [Related]
19. Development of a microwell adapted immunoblot system with recombinant antigens for distinguishing human herpesvirus (HHV)6A and HHV6B and detection of human cytomegalovirus.
Thäder-Voigt A; Jacobs E; Lehmann W; Bandt D
Clin Chem Lab Med; 2011 Nov; 49(11):1891-8. PubMed ID: 21756162
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in a volunteer blood donor population.
Kane RC; Rousseau WE; Noble GR; Tegtmeier GE; Wulff H; Herndon HB; Chin TD; Bayer WL
Infect Immun; 1975 Apr; 11(4):719-23. PubMed ID: 164405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
